微血管和大血管疾病与减重手术后糖尿病缓解的关联
这项回顾性队列研究纳入536例接受Roux-en-Y胃旁路术或袖状胃切除术的2型糖尿病患者,评估术前微血管和大血管糖尿病相关疾病与术后糖尿病缓解的关联。无糖尿病相关疾病者相比有相关疾病者,2型糖尿病缓解的OR为2.72(95%CI 1.92至3.88;27.9% vs 59.4%;p<0.001),且糖尿病相关疾病数量对缓解有累加效应(p<0.001)。合并术前糖尿病相关疾病的患者术后缓解率较低。
要点
- 无糖尿病相关疾病者2型糖尿病缓解率59.4%,有相关疾病者27.9%(p<0.001)。
- 无糖尿病相关疾病者达到2型糖尿病缓解的OR为2.72(95%CI 1.92至3.88)。
- 糖尿病相关疾病数量对2型糖尿病缓解有累加效应(p<0.001)。
核心结论
- 合并术前糖尿病相关疾病的患者在接受Roux-en-Y胃旁路术和袖状胃切除术后糖尿病缓解率较低。
- 这些并发症是预测2型糖尿病缓解的更实用且一致的变量,并有助于对更严重2型糖尿病患者进行多学科管理规划。
研究设计与样本
- 回顾性队列研究,纳入接受Roux-en-Y胃旁路术或袖状胃切除术的2型糖尿病患者,共536例(67%女性,94%白人)。
- 收集术前微血管疾病(视网膜病变、肾病和神经病变)和大血管疾病(冠状动脉疾病、脑血管意外和外周动脉疾病)数据。
- 终点包括糖尿病相关疾病与疾病缓解的关联及累积效应评估,并采用多变量逻辑回归评估与2型糖尿病缓解相关的参数。
主要发现
- 无糖尿病相关疾病患者相比有糖尿病相关疾病患者,达到2型糖尿病缓解的OR为2.72(95%CI 1.92至3.88;27.9% vs 59.4%;p<0.001)。
- 糖尿病相关疾病数量对2型糖尿病缓解有累加效应(p<0.001)。
- HbA1c(p<0.001)、糖尿病药物数量(p<0.001)、2型糖尿病病程(p<0.001)、手术类型(p=0.009)和胰岛素使用(p=0.04)与2型糖尿病缓解显著相关。
临床怎么用
- 作者认为,术前糖尿病相关疾病不仅代表预测2型糖尿病缓解的更实用且一致的变量,也有助于规划更严重2型糖尿病患者的多学科管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type-2 diabetes mellitus (T2DM) results in detrimental vascular complications including both microvascular and macrovascular diseases. Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are effective weight-loss therapies that enhance T2DM remission. However, limited data are present regarding the association between diabetes-associated diseases before RYGB and SG with T2DM remission. METHODS: This is a retrospective cohort study in patients with T2DM who underwent RYGB or SG. We collected data on preoperative microvascular (i.e., retinopathy, nephropathy, and neuropathy) and macrovascular (coronary artery disease, cerebrovascular accidents, and peripheral artery disease) diabetes-associated diseases. Our end points included assessment of association and cumulative effect of diabetes-associated diseases and disease remission. We also performed a multivariate logistic regression to evaluate the parameters associated with T2DM remission. RESULTS: A total of 536 patients (67% female, 94% White) were included in this study. Patients without diabetes-associated diseases had an OR of 2.72 (95% CI 1.92 to 3.88) to achieve T2DM remission compared to patients with diabetes-associated diseases (27.9% vs 59.4%; p < 0.001). Importantly, there was an additive effect of the number of diabetes-associated diseases on the T2DM remission (p < 0.001). We demonstrate a significant association between HbA1c (p < 0.001), number of diabetes medications (p < 0.001), T2DM duration (p < 0.001), surgery type (p = 0.009), and insulin use (p = 0.04) with T2DM remission. CONCLUSION: Patients with presurgical diabetes-associated diseases had a lower remission rate after RYGB and SG. Not only do these complications represent a more practical and consistent variable to predict T2DM remission, but also help planning a multidisciplinary management of patients with more severe T2DM.
引用
- Ghusn W, Salame M, Sayegh L, et al. The association between microvascular and macrovascular diseases and diabetes remission after bariatric surgery. Surg Endosc. 2024. PMID: 38305895. doi:10.1007/s00464-024-10687-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。